Entropion Treatment Market Trends

  • Report ID: 3777
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Entropion Treatment Market - Growth Drivers and Challenges

Growth Drivers

  • Growing Population of Old-Adults - Entropion often only affects the lower eyelid and is more prevalent in older persons. In research of approximately 25,000 people over the age of 60, approximately 2% of patients had involutional entropion. The prevalence of entropion increased with age.

  • Rising Success Rate of Entropion Treatment -Transverse blepharotomy and marginal rotation is a popular treatment for entropion. Moreover, throughout ten days, the bolster and sutures are in place. For the treatment of upper and lower lid cicatricial entropion, this surgery has an 85% success rate.

  • Increased Use of Contact Lenses - A soft contact lens are used to correct the vision, that is compromised due to entropion affected eye. There are around 140 million contact lens wearers in the world. Out of which, nearly 45 million users are in the United States.

  • Rising Prevalence of Dry Eye Syndrome - Dry eye syndrome is a common symptom of entropion eye, it causes itchiness, dryness, and redness. A greater number of people are impacted by dry eyes and decreased tear production. Between 5 to 50 percent of people worldwide have a dry eye condition.

  • Rising Use of Eye Drops - Doctors prescribe the use of mild eye drops to avoid any irritation and redness in the eye. By 2020, at least 3 million people in the UK will use eye drops and ointments daily. Following this, about 2 million people began using eye drops and ointments less frequently than once per month.

Challenges

  • Complications related to eye surgeries - The majority of patients have brief side effects like edoema and bruising after entropion surgery. The market's growth is anticipated to be hampered by the growing concern over additional negative effects related to entropion surgery.
  • Lack of awareness regarding entropion and its treatment
  • High cost of cosmetic treatment for entropion

Base Year

2025

Forecast Year

2026-2035

CAGR

6.8%

Base Year Market Size (2025)

USD 507.6 million

Forecast Year Market Size (2035)

USD 980.02 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of entropion treatment is assessed at USD 538.67 million.

The global entropion treatment market size was valued at over USD 507.6 million in 2025 and is expected to expand at a CAGR of around 6.8%, surpassing USD 980.02 million revenue by 2035.

North America entropion treatment market is anticipated to command a leading revenue share, fueled by the escalating incidence of age-related entropion and widespread dry eye conditions across the elderly population.

Key players in the market include Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., and Alembic Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos